Voltage-dependent mania after subthalamic nucleus deep brain stimulation in Parkinson's disease: A case report

TY - JOUR

T1 - Voltage-dependent mania after subthalamic nucleus deep brain stimulation in Parkinson's disease

T2 - A case report

AU - Chopra, Amit

AU - Tye, Susannah J.

AU - Lee, Kendall H.

AU - Matsumoto, Joseph

AU - Klassen, Bryan

AU - Adams, Andrea C.

AU - Stead, Matt

AU - Sampson, Shirlene

AU - Kall, Bruce A.

AU - Frye, Mark A.

N1 - Funding Information: Mark A. Frye, M.D., reports grant support from Pfizer , National Alliance for Schizophrenia and Depression (NARSAD), National Institute of Mental Health , National Institute of Alcohol Abuse and Alcoholism , and the Mayo Clinic ; has served as consultant with Merck and Sunovian; and reports Continuing Medical Education-supported activity from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Otsuka Pharmaceuticals, Pfizer, and Sanofi-Aventis. Kendall Lee reports patents pending concerning deep brain stimulation technology and has received industry support from St. Jude Neuromodulation Division. Shirlene Sampson, M.D., received funding from the National Institute of Mental Health. Amit Chopra, Susannah J. Tye, Joseph Matsumoto, Bryan Klassen, Andrea C. Adams, Matt Stead, and Bruce A. Kall report no biomedical financial interests or potential conflicts of interest.

PY - 2011/7/15

Y1 - 2011/7/15

UR - http://www.scopus.com/inward/record.url?scp=79959728834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959728834&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2010.12.035

DO - 10.1016/j.biopsych.2010.12.035

M3 - Letter

C2 - 21414603

AN - SCOPUS:79959728834

SN - 0006-3223

VL - 70

SP - e5-e7

JO - Biological psychiatry

JF - Biological psychiatry

IS - 2

ER -